Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue.

Authors: May, Michael S.¹ (AUTHOR) hp2523@cumc.columbia.edu, Park, Heekuk¹ (AUTHOR) dalia.moallem@gmail.com, Moallem, Dalia H.¹ (AUTHOR) ds4057@cumc.columbia.edu, Seeram, Dwayne¹ (AUTHOR) jaj7021@med.cornell.edu, Dajiang, Sun² (AUTHOR) ds2429@cumc.columbia.edu, Hibshoosh, Hanina² (AUTHOR) hhh1@cumc.columbia.edu, Jamison, Jacob K.¹ (AUTHOR) au2110@cumc.columbia.edu, Uhlemann, Anne-Catrin¹ (AUTHOR) gam2140@cumc.columbia.edu, Manji, Gulam A.^1,3 (AUTHOR)

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 1, p140. 15p.

Subject Terms: *PANCREATIC tumors, *NEOADJUVANT chemotherapy, *GASTROINTESTINAL cancer, *CYTIDINE deaminase, *PANCREATIC cancer

Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer

Authors: May, Michael S., Jamison, Jacob K., Wong, Winston, Michel, Alissa, Raufi, Alexander G., Neugut, Alfred I., Manji, Gulam A.

Source: Cancer investigation. 41(5):487-490

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185833436.0x000001&indx=1&recIds=ETOCvdc_100185833436.0x000001

Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data

Authors: Shain, Joshua, Michel, Alissa, May, Michael S., Qunaj, Lindor, El-Sadr, Wafaa, Chung, Wendy K., Appelbaum, Paul S., Jacobson, Judith S., Justman, Jessica, Neugut, Alfred I.

Source: In Seminars in Oncology December 2023 50(6):123-130

Signet ring cell carcinoma of the Ampulla of Vater: outcomes of patients in the United States

Authors: Kinslow, Connor J., May, Michael S., Kozak, Margaret, Pollom, Erqi L., Chang, Daniel T.

Source: In HPB December 2020 22(12):1759-1765

Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study

Authors: Kinslow, Connor J., May, Michael S., Saqi, Anjali, Shu, Catherine A., Chaudhary, Kunal R., Wang, Tony J.C., Cheng, Simon K.

Source: In Clinical Lung Cancer March 2020 21(2):e99-e113

A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.

Authors: Jamison, Jacob K, May, Michael S, Raufi, Alexander G, Luk, Lyndon, Wong, Winston, Mundi, Prabhjot S, Manji, Gulam A

Source: Oncologist; Apr2024, Vol. 29 Issue 4, p350-355, 6p

Subject Terms: ADENOCARCINOMA, BRCA genes, DATA analysis, COMPUTED tomography, CANCER patients, PANCREATIC tumors, CANCER chemotherapy, METASTASIS, CENTRAL nervous system tumors, IMMUNOHISTOCHEMISTRY, GENE expression profiling, STATISTICS, GENETIC mutation, PROGRESSION-free survival, INDIVIDUALIZED medicine, PLATINUM, DISEASE progression

Contribution of neoadjuvant chemotherapy and radiation therapy (intensity-modulated radiation therapy with concurrent chemotherapy versus stereotactic body radiation therapy alone) on tumor volume regression in patients with borderline resectable or...

Authors: Jamison, Jacob K., Cho, Hope, May, Michael S., Luk, Lyndon, Flusberg, Milana, Kobi, Mariya, Beylergil, Volkan, Skorohodova, Ksenia, Raufi, Alexander G, Horowitz, David Paul, Kluger, Michael D., Pan, Samuel M, Kachnic, Lisa A., Schrope, Beth, Bates, Susan Elaine, White, Ruth Aroon, Moy, Ryan H., Wu, Linda, Chabot, John A., Manji, Gulam Abbas

Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p707-707, 117p

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.

Authors: Soni, Mithil K., Migliori, Edoardo, Jianing Fu, Assal, Amer, Hei Ton Chan, Jian Pan, Khatiwada, Prabesh, Ciubotariu, Rodica, May, Michael S., Pereira, Marcus R., Giorgi, Valeria De, Sykes, Megan, Mapara, Markus Y., Muranski, Pawel J.

Source: Frontiers in Immunology; 2023, p1-19, 19p

Subject Terms: T cells, CORONAVIRUSES, SARS-CoV-2 Omicron variant, COVID-19, SARS-CoV-2

Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer.

Authors: Qunaj, Lindor, May, Michael S., Neugut, Alfred I., Herzberg, Benjamin O.

Source: Frontiers in Oncology; 2023, p1-8, 8p

Subject Terms: RAS oncogenes, COLORECTAL cancer, NON-small-cell lung carcinoma, PANCREATIC duct, PANCREATIC cancer

Improved survival in patients with lung only recurrence after surgical resection of pancreatic ductal adenocarcinoma.

Authors: May, Michael S., Michel, Alissa, Lee, Tristan, Wong, Winston, Jamison, Jacob K.R., Manrique, David, Pan, Samuel M, Hu, Jianhua, Safyan, Rachael A, Raufi, Alexander, Kluger, Michael, Bates, Susan Elaine, Chabot, John A., Manji, Gulam Abbas

Source: Journal of clinical oncology. 40(4 suppl):608-608

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152971958.0x000001&indx=1&recIds=ETOCvdc_100152971958.0x000001

Neoadjuvant gemcitabine, docetaxel, and capecitabine results in comparable surgical outcomes to modified FOLFIRINOX in patients with pancreatic ductal adenocarcinoma who also receive radiation: A single institution experience.

Authors: Wong, Winston, Jamison, Jacob K.R., May, Michael S., Michel, Alissa, Lee, Tristan, Manrique, David, Raufi, Alexander, Pan, Samuel M, Safyan, Rachael A, Horowitz, David Paul, Schrope, Beth, Kluger, Michael, Kachnic, Lisa A., Hu, Jianhua, Bates, Susan Elaine, Chabot, John A., Manji, Gulam Abbas

Source: Journal of clinical oncology. 40(4 suppl):565-565

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152970392.0x000001&indx=1&recIds=ETOCvdc_100152970392.0x000001

Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.

Authors: Raufi, Alexander G.^1,2,3 (AUTHOR) alexander_raufi@brown.edu, May, Michael S.⁴ (AUTHOR), Hadfield, Matthew J.^1,2 (AUTHOR), Seyhan, Attila A.^2,3,5 (AUTHOR), El-Deiry, Wafik S.^1,2,3,5 (AUTHOR)

Source: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 4, p4238. 25p.

Subject Terms: *PANCREATIC cancer, *CIRCULATING tumor DNA, *BIOPSY, *LIQUIDS, *DNA

CheMo4METPANC: A phase 2 study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment-naïve pancreas...

Authors: Manji, Gulam Abbas, May, Michael S., Pellicciotta, Ilenia, Sta Ana, Sarah, Sender, Naomi, Pan, Samuel M, Ross, Isabelle, Hu, Jianhua, Shi, Qian, Raufi, Alexander G

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS4200-TPS4200, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.